Home Carboxys 4-Oxo-2-azetidinecarboxylic acid

4-Oxo-2-azetidinecarboxylic acid

CAS No.:
98019-65-9
Catalog Number:
AG00H6MO
Molecular Formula:
C4H5NO3
Molecular Weight:
115.0874
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
95%
In Stock USA
United States
$113
- +
Product Description
Catalog Number:
AG00H6MO
Chemical Name:
4-Oxo-2-azetidinecarboxylic acid
CAS Number:
98019-65-9
Molecular Formula:
C4H5NO3
Molecular Weight:
115.0874
MDL Number:
MFCD00798160
IUPAC Name:
4-oxoazetidine-2-carboxylic acid
InChI:
InChI=1S/C4H5NO3/c6-3-1-2(5-3)4(7)8/h2H,1H2,(H,5,6)(H,7,8)
InChI Key:
YSPMLLKKKHCTBN-UHFFFAOYSA-N
SMILES:
O=C1CC(N1)C(=O)O
Properties
Complexity:
142  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
115.027g/mol
Formal Charge:
0
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
115.088g/mol
Monoisotopic Mass:
115.027g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
66.4A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.1  
Literature
Title Journal
Ring splitting of azetidin-2-ones via radical anions. Organic & biomolecular chemistry 20121021
An expeditious iodine-catalyzed synthesis of 3-pyrrole-substituted 2-azetidinones. Molecules (Basel, Switzerland) 20120928
Photoelectron spectra of some antibiotic building blocks: 2-azetidinone and thiazolidine-carboxylic acid. The journal of physical chemistry. A 20120823
An expeditious route to eight-membered heterocycles by nickel-catalyzed cycloaddition: low-temperature C(sp)2-C(sp)3 bond cleavage. Angewandte Chemie (International ed. in English) 20120820
Kappa agonist CovX-Bodies. Bioorganic & medicinal chemistry letters 20120615
Regioselective cycloaddition of 3-azetidinones and 3-oxetanones with alkynes through nickel-catalysed carbon-carbon bond activation. Chemistry (Weinheim an der Bergstrasse, Germany) 20120319
Synthesis and bioactivities of 2-azetidinone derivatives as cholesterol absorption inhibitors. Medicinal chemistry (Shariqah (United Arab Emirates)) 20111101
Antibacterial agents and cystic fibrosis: synthesis and antimicrobial evaluation of a series of N-thiomethylazetidinones. ChemMedChem 20111004
Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives. Bioorganic & medicinal chemistry letters 20110801
Synthesis of spirocyclic β-keto-lactams: copper catalyzed process. Chemical communications (Cambridge, England) 20110507
Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-ones. Bioorganic & medicinal chemistry 20110401
Monocyclic β-lactams: new structures for new biological activities. Current medicinal chemistry 20110101
2-Azetidinone--a new profile of various pharmacological activities. European journal of medicinal chemistry 20101201
Synthesis of chlorinated bicyclic C-fused tetrahydrofuro[3,2-c]azetidin-2-ones. The Journal of organic chemistry 20101105
Ferrier-Petasis rearrangement of 4-(vinyloxy)azetidin-2-ones: an entry to carbapenams and carbacephams. The Journal of organic chemistry 20101015
T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis. Bioorganic & medicinal chemistry letters 20100801
Azetidinone-isothiazolidinones: stereoselective synthesis and antibacterial evaluation of new monocyclic beta-lactams. Bioorganic & medicinal chemistry 20100501
Synthesis, in-vitro antimicrobial and cytotoxic studies of novel azetidinone derivatives. Archiv der Pharmazie 20100401
Suppressed beta-effect of silicon in 3-silylated monocyclic beta-lactams: the role of antiaromaticity. Organic letters 20091217
Design, synthesis and bioactivity of catechin/epicatechin and 2-azetidinone derived chimeric molecules. Bioorganic & medicinal chemistry letters 20091215
2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study. European journal of medicinal chemistry 20091201
Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors. ChemMedChem 20091201
Lewis acid-assisted ene cyclization of 2-azetidinone-tethered enals: synthesis of enantiopure carbacepham derivatives. Chemistry, an Asian journal 20091005
Staudinger ketene-imine cycloaddition, RCM approach to macrocrocyclic bisazetidinones. The Journal of organic chemistry 20090605
Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies. European journal of medicinal chemistry 20090501
2-Azetidinone derivatives: design, synthesis and evaluation of cholesterol absorption inhibitors. European journal of medicinal chemistry 20090401
Spiro-piperidine azetidinones as potent TRPV1 antagonists. Bioorganic & medicinal chemistry letters 20090201
Deeper insight into the mechanism of the reaction of photogenerated metallaketenes and imines. Journal of the American Chemical Society 20081022
Novel syntheses of azetidines and azetidinones. Chemical reviews 20080901
3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. Bioorganic & medicinal chemistry letters 20080715
Total synthesis of (-)-kainic acid via intramolecular Michael addition: a second-generation route. Organic letters 20080501
Discovery of azetidinone acids as conformationally-constrained dual PPARalpha/gamma agonists. Bioorganic & medicinal chemistry letters 20080315
New regiocontrolled synthesis of functionalized pyrroles from 2-azetidinone-tethered allenols. Chemistry (Weinheim an der Bergstrasse, Germany) 20080101
Synthesis and biological activity of N-substituted-3-chloro-2-azetidinones. Molecules (Basel, Switzerland) 20071112
Synthesis of novel N-(4-ethoxyphenyl) azetidin-2-ones and their oxidative N-deprotection by ceric ammonium nitrate. Molecules (Basel, Switzerland) 20071025
Synthesis of 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-[(substituted azetidinone/thiazolidinone)-aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent. Bioorganic & medicinal chemistry 20070415
Azetidinones as vasopressin V1a antagonists. Bioorganic & medicinal chemistry 20070301
Indium-mediated selective introduction of a 1,3-butadien-2-yl group at the C4-position in 2-azetidinones and application of 1,3-diene-tethered 2-azetidinones in the Diels-Alder reaction. Chemistry (Weinheim an der Bergstrasse, Germany) 20070101
A theoretical proposal for the synthesis of carbapenems from 4-(2-propynyl)azetidinones promoted by [W(CO)5] as an alternative to the Ag+-assisted process. Chemistry (Weinheim an der Bergstrasse, Germany) 20061016
Structures of (S)-(-)-4-oxo-2-azetidinecarboxylic acid and 3-azetidinecarboxylic acid from powder synchrotron diffraction data. Acta crystallographica. Section B, Structural science 20060801
Synthesis of strained tricyclic beta-lactams by intramolecular [2+2] cycloaddition reactions of 2-azetidinone-tethered enallenols: control of regioselectivity by selective alkene substitution. Chemistry (Weinheim an der Bergstrasse, Germany) 20060201
The polymer-supported and combinatorial synthesis of beta-lactam compounds: an update. Mini reviews in medicinal chemistry 20060101
Rabbit small intestine does not contain an annexin II/caveolin 1 complex as a target for 2-azetidinone cholesterol absorption inhibitors. Biochimica et biophysica acta 20060101
Synthesis of 2-azetidinones from 2-diazo-1, 2-diarylethanones and N-(2-thienylidene)imines as possible antimicrobial agents. Farmaco (Societa chimica italiana : 1989) 20050901
The indium-mediated selective introduction of allenyl and propargyl groups at the C4-position of 2-azetidinones and the AuCl3-catalyzed cyclization of 4-allenyl-2-azetidinones. Angewandte Chemie (International ed. in English) 20050311
3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity. Bioorganic & medicinal chemistry letters 20050301
Kinetics and mechanism of hydrolysis of N-acyloxymethyl derivatives of azetidin-2-one. The Journal of organic chemistry 20040514
Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design. Bioorganic & medicinal chemistry letters 20040503
Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorganic & medicinal chemistry letters 20040503
Synthesis of optically pure highly functionalized gamma-lactams via 2-azetidinone-tethered iminophosphoranes. The Journal of organic chemistry 20040206
Synthesis of antitumor 6-alkylidenepenicillanate sulfones and related 3-alkylidene-2-azetidinones. Bioorganic & medicinal chemistry letters 20040105
Synthesis and evaluation of N1/C4-substituted beta-lactams as PPE and HLE inhibitors. Bioorganic & medicinal chemistry 20040102
Synthesis of cryptophycins via an N-acyl-beta-lactam macrolactonization. The Journal of organic chemistry 20031212
Synthesis of a biotin-tagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors. Bioorganic & medicinal chemistry 20030417
Catalysts with mixed ligands on immobilized supports. Electronic and steric advantages. Organic letters 20030220
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorganic & medicinal chemistry letters 20021104
A stereoselective synthesis of BMS-262084, an azetidinone-based tryptase inhibitor. The Journal of organic chemistry 20020531
General approach for the stereocontrolled construction of the beta-lactam ring in amino acid-derived 4-alkyl-4-carboxy-2-azetidinones. The Journal of organic chemistry 20020531
Water-assisted alkaline hydrolysis of monobactams: a theoretical study. Chemistry (Weinheim an der Bergstrasse, Germany) 20020215
Synthesis of iodinated biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors. Bioorganic & medicinal chemistry letters 20020211
Synthesis of fluorescent biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors. Bioorganic & medicinal chemistry letters 20020211
Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors. Bioorganic & medicinal chemistry 20011101
Metal-promoted allylation, propargylation, or allenylation of azetidine-2,3-diones in aqueous and anhydrous media. Application to the asymmetric synthesis of densely functionalized 3-substituted 3-hydroxy-beta-lactams. The Journal of organic chemistry 20010727
Crystal structure of 3,3-dichloro-N-p-methoxyphenyl-4-(2-phenylstryl)-2-azetidinone. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20010701
Entry to new conformationally constrained amino acids. First synthesis of 3-unsubstituted 4-alkyl-4-carboxy-2-azetidinone derivatives via an intramolecular N(alpha)-C(alpha)-cyclization strategy. The Journal of organic chemistry 20010518
beta-lactam derivatives as enzyme inhibitors: carboxy peptidyl derivatives of (S)-4-oxoazetidine-2-carboxylate as peptidomimetics. Archiv der Pharmazie 20010501
Design, synthesis and stability of N-acyloxymethyl- and N-aminocarbonyloxymethyl-2-azetidinones as human leukocyte elastase inhibitors. Bioorganic & medicinal chemistry letters 20010423
Synthesis of trans-4-aryl-3-(omega-chloroalkyl) -2-azetidinones. Mededelingen (Rijksuniversiteit te Gent. Fakulteit van de Landbouwkundige en Toegepaste Biologische Wetenschappen) 20010101
Properties